In 2023, the United States led global government budget appropriations for R&D in health at USD 64.29 billion, despite a 14.95% decrease from the previous year. Japan followed with a 5.48% increase, reaching USD 47.92 billion. While the Netherlands and Austria experienced significant increases of 77.69% and 79.47%, their absolute values remain significantly lower than the US or Japan. In contrast, Slovakia and Hungary saw notable declines. Over the last five years, the sector has shown varied growth, with countries like the Netherlands and Austria emerging as new contributors to the R&D landscape.
Future trends to watch include:
- Continued growth potential in European countries with recent increases, such as the Netherlands and Austria.
- Possible strategies from the United States to reverse recent declines and maintain leadership in R&D expenditure.
- The impact of economic conditions and global health priorities on national R&D budgets.
Top countries in Government Budget Appropriations or Outlays for R&D in Health by Country
| # | 10 Countries | Million US Dollars PPP | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 United States | 64,290 | 2023 | -3.34% | -14.95% | View data |
| 2 | 2 Japan | 47,920 | 2023 | +4.62% | +5.48% | View data |
| 3 | 3 Russia | 18,040 | 2023 | +1.24% | +1.22% | View data |
| 4 | 4 France | 17,370 | 2023 | +3.5% | -1.2% | View data |
| 5 | 5 Netherlands | 6,520 | 2023 | +5.71% | +77.69% | View data |
| 6 | 6 Austria | 3,810 | 2023 | +6.45% | +79.47% | View data |
| 7 | 7 Denmark | 3,540 | 2023 | +5.25% | +3.73% | View data |
| 8 | 8 Czech Republic | 2,700 | 2023 | +4.42% | +65.77% | View data |
| 9 | 9 Australia | 2,190 | 2023 | -0.75% | -15.43% | View data |
| 10 | 10 Portugal | 1,220 | 2023 | +4.07% | -0.16% | View data |
